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Transfection of Small Numbers of Human Endothelial Cells by 
Electroporation and Synthetic Amphiphiles 
E. B. M. van Leeuwen1,2, A. Y. van der Veen3, D. Hoekstra4, J. B. F. N. Engberts5, M. R. Halie1,2, 
J. van der Meer2 and M. H. J. Ruiters*1 
1Centre for Biomedical Technology, 2Department of Haematology, Division of Haemostasis, Thrombosis and Rheology, 
3Department of Medical Genetics, 4Department of Physiological Chemistry and 5Department of Organic and Molecular 
Inorganic Chemistry, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands 
Objectives: this study compared the efficiency of electroporation and synthetic amphiphiles (SAINT-2pp/DOPE) in 
transfecting small numbers of human endothelial cells. 
Methods and results: optimal transfection conditions were tested and appeared to be 400 V and 960 mF for electroporation 
and a 10:1 ratio for concentrations of SAINT-2pp/DOPE: plasmid. Using these conditions, cell concentrations were lowered 
step-wise and we were able to transfect as few as one thousand cells with both methods. For detection of transfection of a 
small number of cells a sensitive assay was needed (Luciferase). A plasmid containing the neomycin resistance gene was 
used to determine the transfection rate expressed in colony forming units by counting colonies after selection. At low 
plasmid concentrations this transfection rate was within the same range for both electroporation and SAINT-2pp/DOPE 
transfection. Fluorescent in situ hybridisation of metaphase chromosomes of transfected endothelial cells using the plasmid 
as a probe showed that stable integration was possible with both methods. 
Conclusions: electroporation and a synthetic amphiphile, SAINT-2pp, provide the possibility of transfecting small numbers 
of cells resulting in stable integration of low plasmid concentrations. The availability of this technology is important in 
order to obtain functional endothelial cell lines from various human blood vessels for research purposes. 
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Introduction 
Various vascular disorders, such as deep vein throm-
bosis, myocardial infarction and graft occlusion, are 
related to injury or functional abnormalities of endo-
thelial cells (EC). In order to investigate the role of EC 
it may be valuable to culture EC from blood vessels in 
which these disorders actually occur. However, these 
vessels cannot easily be obtained and only a small 
amount of material will be available. Furthermore, 
cultures of human EC have a limited life span and 
lose their original functions during culture, so it 
would be useful to produce cell lines with an infinite 
life span which have preserved their original 
haemostatic functions. In this study we used human 
umbilical vein endothelial cells (HUVEC) as a model 
to transfect effectively a minimal number of EC. 
Commonly used non-infectious methods for trans-
fection  of  mammalian  cells  are   calcium   phosphate
precipitation, DEAE-dextran mediated transfection, 
lipofection and electroporation. For EC, calcium phos-
phate and DEAE-dextran are less effective.1-7 As for 
lipofection of EC, varying results have been reported, 
depending on the cationic lipid used.1-5,7,8 Successful 
attempts have been made to improve these methods 
by using strontium phosphate instead of calcium phos-
phate,3 or Apo E-mediated lipofection.5 Nevertheless, 
electroporation is still the most efficient transfection 
method for EC, in spite of the low cell viability.3,4,7-12 
SAINT-2pp is a novel synthetic amphiphile, the syn-
thesis of which was recently reported.13 It appeared to 
be less toxic than other amphiphiles used for 
lipofection.14 Moreover, this compound, mixed with 
DOPE (1:1), transfects cells with an efficiency of an 
order of magnitude better than that obtained for li-
pofection, which has been most commonly used for 
transfection thus far. In this study we compared 
SAINT-2pp/DOPE mediated lipofection with electro-
poration in their efficiency to transfect small numbers 
of HUVEC. * Please address all correspondence to: M. H. J. Ruiters, Centre for Biomedical Technology, University of Groningen, PO Box 145, 9700 
AC Groningen, The Netherlands. 
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Materials and Methods 
Materials 
Chymotrypsin and gelatin were obtained from Sigma 
Chemical Co (U.S.A.). Tryptin/EDTA, RPMI 1640 and 
L-glutamine came from Gibco (Scotland). Heparin was 
used from Leo Pharmaceutical Products B.V. (The 
Netherlands). Streptomycin was obtained from Ra-
diumfarma-Fisiopharma (Italy) and penicillin from Ya-
manouchi Pharma B.V. (The Netherlands). Tissue 
culture flasks (25, 75 and 165 cm2), 100 mm cell culture 
dishes, 6-well clusters and cell scrapers were pur-
chased from Costar (U.S.A.). 
Reporter plasmids (pCAT control vector and 
pCMVLuc), cell lysis buffers and luciferase substrate 
came from Promega (U.S.A.). Electroporation cuvettes 
were obtained from BIO-RAD (U.S.A.). SAINT-2pp was 
synthesised as previously described.13 DOPE was pur-
chased from Avanti Polar Lipids Inc. (U.S.A.). 14C-
labeled chloramphenicol was obtained from Amer-
sham (U.S.A.), n-butyryl-CoA from Fluka (Swit-
zerland) and mixed xylenes from Sigma-Aldrich (The 
Netherlands). Scintillation fluid (ultima gold XR) came 
from Packard (U.S.A.). Thin-layer plates were pur-
chased from Merck (Germany) and radiographic films 
(Kodak X-omat) from Sigma Chemical Co (U.S.A.). 
pMC1NeoPolyA was used from Stratagene (U.S.A.). 
Geneticin (G418) was obtained from Boehringer Mann-
heim (Germany). 
Cell culture 
Endothelial cells were isolated from human umbilical 
veins (HUVEC) according to the method of Jaffe et al.,15
except that 0.1 mg/ml chymotrypsin resuspended in 
phosphate-buffered saline (PBS; 140 mM NaCl, 9.0 mM 
Na2HPO4 and 1.3 mM NaH2PO4) was used instead of 
collagenase. This modification provides a higher yield 
of EC with fewer contaminating smooth muscle cells.16
Primary isolates were cultured in 1% gelatin-precoated 
25 cm2 tissue culture flasks at 37 °C under 5% CO2/ 
95% air. The culture medium consisted of RPMI 1640 
supplemented with 20% heat-inactivated human 
serum, 2 mM L-glutamine, 5 U/ml heparin, 50 mg/ml 
EC growth factor supplement extracted from bovine 
hypothalamus,17 100 mg/ml streptomycin, and 100 U/ 
ml penicillin. After attaining confluence, cells were 
detached from the surface by trypsin/EDTA (0.5/ 
0.2 mg/ml) and split at a 1:3 ratio. Cells were counted 
with a Coulter counter and used for experiments up to 
passage five; no differences in transfection rate were 
observed between these passages. 
Electroporation 
HUVEC were transfected by electroporation with a 
Gene Pulser (BIO-RAD) at 200-400 V and 250-960 mF 
(n = 1). Electroporations were performed with 106 cells 
and 10 mg pCAT in 600 ml culture medium in a 0.4 cm 
cuvette. After electroporation cells were transferred 
into 100 mm cell culture dishes with 10 ml of culture 
medium. Optimal voltage and capacity were used for 
further experiments. Cell concentrations were lowered 
step-wise from 5 ´ 106 to 102 cells per electroporation 
(n = 1) and a more sensitive reporter system was used 
(pCMVLuc). When fewer than 105 cells were electro-
porated, they were transferred into 6-well clusters 
with 2 ml of culture medium. 
SAINT-2pp/DOPE transfection 
The day before transfection, 2 ´ 105 HUVEC were trans-
ferred into 6-well clusters. The next day the cells were 
washed twice with Hepes-buffered saline (HBS; 20 mM 
Hepes, 150 mM NaCl, pH 7.4). Amounts of 10-50 nmol 
SAINT-2pp/DOPE were mixed with 1 mg pCMVLuc 
(ratios 10:1 to 50:1) in 1 ml of HBS and added to the 
cells (n = 1). After incubation for 4 h at 37 °C, 1 ml 
culture medium was added for further incubation 
overnight. The optimal ratio was used in combination 
with cell concentrations lowered step-wise from 2 ´ 105
to 102 cells per transfection (n = 1). 
CAT assay 
The following procedure was used to measure chlor-
amphenicol acetyl transferase (CAT) activity.18 Two 
days after transfection, cell extracts were made with 
reporter lysis buffer and cell remnants were removed 
by centrifugation. The supernatant was incubated for 
4.5 h with 75 nCi 14C-labeled chloramphenicol and 
25 mg n-butyryl-CoA in Tris-buffer (0.25 M, pH 8.0) at 
37 °C. 
For liquid scintillation counting (LSC), mixed xy-
lenes were added. The organic phase was transferred 
to a scintillation vial filled with scintillation fluid and 
measured in a liquid scintillation counter (Packard). 
The amount of radioactivity expressed in dis-
integrations per minute (dpm) correlates with the CAT 
activity. 
For thin layer chromatography (TLC), ethyl acetate 
was added. The organic phase was dried and in a 
small volume of ethyl acetate the samples were applied 
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to the thin-layer plate. After chromatography with 
chloroform/methanol (19:1), CAT activity was visu-
alised by the intensity of black spots on a radiographic 
film. 
Luciferase assay 
To measure luciferase activity,19 cell extracts were made 
with cell culture lysis reagent one day after transfection 
and cell remnants were removed by centrifugation. 
Luciferase assay substrate was added to the super-
natant and luminescence was measured (Lucy-1, An-
thos). The amount of luminescence expressed in 
relative light units (rlu) correlates with the luciferase 
activity. 
Transfection rate 
Electroporation and SAINT-2pp/DOPE transfection of 
105 HUVEC were performed with various con-
centrations of pMC1NeoPolyA (n ³ 4). One day after 
transfection, cells were provided with fresh culture 
medium; on the second day they were transferred to a 
larger surface. G418 was added at a concentration of 
400 mg/ml for at least 8 days. Cell doubling of each 
transfected cell which survived the process caused the 
formation of one colony. These colonies were counted 
by light microscopy and the transfection rate was 
expressed in colony-forming units (1 CFU = formation 
of one colony when 1 mg plasmid and 105 EC were 
used). 
Fluorescent in situ hybridisation 
EC cultured after transfection with pMC1NeoPolyA 
were detached from the surface of the culture flask by 
trypsin/EDTA, subjected to hypotonic treatment with 
0.025 M KCl, fixed in methanol-acetic-acid, 3:1 (v/v) 
and dropped onto slides according to standard 
procedures for the preparation of metaphase spreads. 
Fluorescent in situ hybridisation (FISH) was performed 
on the preparations according to standard laboratory 
protocols using as a probe the biotinylated plasmid 
pMC1NeoPolyA. Integration of the plasmid was as-
sessed by fluorescence microscopy. 
Fig. 1. Transfection by electroporation with pCAT at different volt-
ages and capacities. Electroporation of 106 HUVEC with 10 mg pCAT 
in 600 ml culture medium in a 0.4 cm cuvette at 200, 250, 300, 350 and 
400 V; and 250, 500 and 960 mF (n = 1). CAT activity is expressed in 
dpm. (q) 200 V; (    ) 250 V; (n) 300 V; (    ) 350 V; (    ) 400 V. 
Statistics 
The results shown in Fig. 6 are presented as mean 
values and standard deviations of at least four ex-
periments. To compare the CFU-values at different 
concentrations of plasmid, the unpaired t-test was 
used. 
Results 
To determine optimal electroporation conditions for 
HUVEC, five different voltages (200, 250, 300, 350 and 
400 V) were used at three different capacities (250, 500 
and 960 mF). Figure 1 shows that an increase of voltage 
and capacity resulted in an increase of CAT activity. 
HUVEC even survived 400 V and 960 mF, which res-
ulted in the highest CAT activity. These optimal con-
ditions were used to determine the minimum amount 
of HUVEC still expressing CAT activity after elec-
troporation. Figure 2 shows that decreasing the amount 
of cells resulted in a decreased CAT activity. At 105
HUVEC almost no CAT activity was left. 
SAINT-2pp/DOPE transfections of HUVEC resulted 
in CAT activities fluctuating around background val-
ues, as measured with LSC (results not shown). TLC 
was used to visualise the product formed by the CAT 
enzyme. However, no black spots could be detected on 
the radiographic film in case of SAINT-2pp/DOPE 
transfections. Even for electroporation, when the high-
est CAT activity measured by LSC was used, only a 
very  weak  spot  was  present  after  TLC   (results   not 
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Fig. 2. Transfection by electroporation with pCAT and different 
amount of cells. Electroporation of 5 ´ 106, 3 ´ 106, 106, 105, 104, 103
and 102 HUVEC with 10 mg pCAT in 600 ml culture medium in a 
0.4 cm cuvette at 960 mF and 400 V (n = 1). CAT activity is expressed 
in dpm. 
shown). Therefore a switch was made to a more sens-
itive reporter system (pCMVLuc). 
Electroporation with decreasing amounts of HUVEC 
was repeated with pCMVLuc instead of pCAT. Figure 
3 shows a decrease of luciferase activity when fewer 
cells were electroporated. Compared with the CAT 
assay, the luciferase assay was a hundred-fold more 
sensitive. At 103 HUVEC there was still some activity 
present. In case of SAINT-2pp/DOPE transfections, lu-
ciferase activities were much higher than background 
values. Figure 4 shows that an increasing concentration 
of SAINT-2pp/DOPE at a constant plasmid con-
centration resulted in a decreased luciferase activity. 
At the conditions tested, the highest activity was found 
when 10 nmol/ml was used at a plasmid concentration 
of 1 mg/ml (ratio 10:1). This ratio was used to determine 
the minimum amount of HUVEC still expressing lu-
ciferase  activity  after  SAINT-2pp/DOPE  transfection. 
Fig. 3. Transfection by electroporation with pCMVLuc and different 
amount of cells. Electroporation of 106, 105, 104, 103 and 102 HUVEC 
with 10 mg pCMVLuc in 600 ml culture medium in a 0.4 cm cuvette 
at 960 mF and 400 V (n = 1). Luciferase activity is expressed in rlu. 
Fig. 4. Comparison of different concentrations SAINT-2pp/DOPE. 
Transfection of 2 ´ 105 HUVEC in a 6-well cluster with 10, 20, 30, 40 
and 50 nmol SAINT-2pp/DOPE and 1 mg pCMVLuc (ratios 10:1 to 
50:1) in 1 ml HBS for 4 h (n = 1). Luciferase activity is expressed in 
rlu. 
Fig. 5. SAINT-2pp/DOPE transfection with pCMVLuc and different 
amount of cells. Transfection of 2 ´ 105, 105, 104, 103 and 102 HUVEC 
in a 6-well cluster with 10 nmol SAINT-2pp/DOPE and 1 mg 
pCMVLuc in 1 ml HBS for 4 h (n = 1). Luciferase activity is expressed 
in rlu. 
Figure 5 shows that a decreasing amount of cells 
resulted in a decreased luciferase activity. Again, even 
with only 103 HUVEC activity was present. Figures 1-5 
show the results of one representative experiment. 
More experiments were performed, but in transient 
transfection assays the absolute values on the y-axis 
cannot be compared between different experiments. 
To investigate whether either transfection method 
has an advantage over the other in forming colonies, 
pMC1NeoPolyA was used instead of pCMVLuc. More 
colonies were counted with a higher plasmid con-
centration for electroporation was  used.  Although,  at 
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Fig. 6. Comparison of two transfection methods at different plasmid 
concentrations. Electroporation of 105 HUVEC with 1, 2.5, 5, 10 and 
25 mg pMC1NeoPolyA. SAINT-2pp/DOPE transfection of 105 HUVEC 
with 1, 2.5, 5 and 10 mg pMC1NeoPolyA. Optimal transfection 
coditions were used and colonies were counted after selection with 
G418. Transfection rate is expressed in colony-forming units (CFU = 
amount of colonies per mg plasmid per 105 EC) ± S.D. (n ³ 4). (q) 
Electr; (    ) SAINT-2. 
Fig. 7. FISH of the plasmid used for transfection of EC on metaphase 
chromosomes of transfected EC. Specific hybridisation on a chro-
mosome was detected with fluorescein-avidin (yellow green) in 
combination with goat anti-avidin. Total DNA was stained with 
propidium iodide (red). 
low plasmid concentrations (1 and 2.5 mg) Figure 6 
shows a higher CFU (significant, p<0.05). In case of 
SAINT-2pp/DOPE transfection colonies were counted 
only at low plasmid concentrations. At 5 and 10 mg 
plasmid, the transfection mixture, which also con-
tained 50 and 100 nmol synthetic amphiphiles (ratio 
10:1), became toxic for the cells.13,14 Figure 6 shows that 
the CFU for both methods was about the same at low 
concentrations of plasmid (not significant, p<0.1). 
Figure 7 shows, by using FISH, that integration of the 
plasmid occurred in one chromosome per transfected 
EC. 
Discussion 
Both electroporation and lipofection with SAINT-2pp/ 
DOPE appeared to be efficient transfection methods 
for EC. Electroporation should be performed at 400 V 
and 960 mF and similar optimal conditions have been 
reported before by Kotnis et al.11 In the case of SAINT-
2pp/DOPE transfection the ratio 10:1 (nmol SAINT-
2pp/DOPE:mg plasmid) should be used instead of 
higher ratios, in order to get better transfection. Syn-
thetic amphiphile mediated transfections are usually 
performed with 1 mg of plasmid13,14 and electro-
porations with up to 50 mg. This study therefore 
started with 1 mg for SAINT-2pp/DOPE transfection 
and 10 mg for electroporation. When we used a sens-
itive transient expression assay (luciferase instead of 
CAT), we were able to detect activity with both trans-
fection methods in as few as one thousand EC. This is 
important for the production of functional endothelial 
cell lines from various human blood vessels, because 
only small amounts of material are available. If 
isolation results in only a few EC, transfection can be 
performed shortly after isolation, when it can be 
assumed that most of the specific EC functions are still 
present. 
The plasmids used contained the reporter genes 
chloramphenicol acetyltransferase or luciferase, which 
cannot be used to determine the percentage of trans-
fected cells. As production of cell lines requires the 
outgrowth of colonies, both transfection methods were 
also compared using the neomycin resistance gene. 
When only a few cells are available and there is no 
limitation for the use of high plasmid concentrations, 
electroporation provides for the highest yield of col-
onies. At low plasmid concentrations the transfection 
rate expressed in CFU was within the same range. 
FISH of the plasmid used for transfection of EC on 
metaphase chromosomes of transfected EC was per-
formed after long-term culture and showed that in-
tegration of the plasmid occurred after transfection in 
both ways. So SAINT-2pp/DOPE mediated lipofection 
appeared to be as effective as electroporation. 
In conclusion, this study shows that as few as 1000 
EC can be transfected by electroporation and with 
SAINT-2pp/DOPE. Both methods result in stable in-
tegration of the plasmid and at low plasmid con-
centrations, they also have the same transfection rate. 
Transfection of small numbers of EC shortly after 
isolation will reduce the risk of losing original func-
tions before transfection. This is important to obtain 
functional endothelial cell lines from various human 
blood vessels for research purposes such as thrombosis 
in vascular diseases. Transfections of adult venous and 
arterial cells are in progress. 
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